Core Insights - Haisheng Pharmaceutical (870656.BJ) released its semi-annual report for 2025 on August 21, 2025, indicating a total of 8 institutional investors holding shares in the company [1] - The total shareholding by institutional investors reached 4.27% of Haisheng Pharmaceutical's total equity, amounting to 4.2697 million shares [1] - Compared to the previous quarter, the proportion of shares held by institutional investors increased by 0.45 percentage points [1] Institutional Holdings - Eight institutional investors disclosed their holdings in Haisheng Pharmaceutical A-shares [1] - The institutional investors include Qizhou Youming Enterprise Management Partnership (Limited Partnership), clients of Kaiyuan Securities Co., Ltd., clients of China International Capital Corporation Wealth Securities Co., Ltd., and Shandong Yixing Venture Capital Co., Ltd. [1] - The cumulative holding ratio of institutional investors rose to 4.27% from the previous quarter [1]
机构风向标 | 海昇药业(870656)2025年二季度已披露持仓机构仅8家